Health Library

Keratosis pilaris

KP; Chicken skin; Follicular keratosis; Follicular hyperkeratosis

Keratosis pilaris is a common skin condition in which a protein in the skin called keratin forms hard plugs within hair follicles.

Images

I Would Like to Learn About:

Causes

Keratosis pilaris is a harmless condition. It seems to run in families. It is more common in people who have very dry skin, or who have atopic dermatitis (eczema).

The condition is generally worse in winter and often clears in the summer.

Symptoms

Symptoms may include:

• Small bumps that look like "goose bumps" on the back of the upper arms and thighs
• Bumps feel like very rough sandpaper
• Skin-colored bumps are the size of a grain of sand
• Slight pinkness may be seen around some bumps
• Bumps may appear on the face and be mistaken for acne

Exams and Tests

Your health care provider can usually diagnose this condition by looking at your skin. Tests are often not needed.

Treatment

Treatment may include:

• Moisturizing lotions to soothe the skin and help it look better
• Skin creams that contain urea, lactic acid, glycolic acid, salicylic acid, tretinoin, or vitamin D
• Steroid creams to reduce redness

Improvement often takes months, and the bumps are likely to come back if you stop using the medicine.

Outlook (Prognosis)

Keratosis pilaris may fade slowly with age.

When to Contact a Medical Professional

Contact your provider if the bumps are bothersome and do not get better with lotions you buy without a prescription.

Related Information

References

Bell MA, Grossberg AL. Keratosis pilaris and variants. In: Lebwohl MG, Heymann WR, Coulson IH, Murrell DF, eds. Treatment of Skin Disease. 6th ed. Philadelphia, PA: Elsevier; 2022:chap 125.

Patterson JW. Diseases of cutaneous appendages. In: Patterson JW, ed. Weedon's Skin Pathology. 6th ed. Philadelphia, PA: Elsevier; 2025:chap 16.

Review Date: 11/20/2025  

Reviewed By: Ramin Fathi, MD, FAAD, Director, Phoenix Surgical Dermatology Group, Phoenix, AZ. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- 2026 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.